tiprankstipranks
Kane Biotech Inc (TSE:KNE)
TSXV:KNE
Canadian Market

Kane Biotech (KNE) Financial Statements

0 Followers

Kane Biotech Financial Overview

Kane Biotech's market cap is currently ―. The company's EPS TTM is C$-0.034; its P/E ratio is -4.07; Kane Biotech is scheduled to report earnings on August 22, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total RevenueC$ -1.90MC$ 717.85KC$ 657.31KC$ 677.62K-
Gross ProfitC$ -881.35KC$ 315.26KC$ 330.50KC$ 345.05K-
EBITC$ -637.84KC$ -1.17MC$ -536.72KC$ -1.00M-
EBITDAC$ -589.54KC$ -1.10MC$ -471.96KC$ -941.68K-
Net Income Common StockholdersC$ -1.58MC$ -1.38MC$ -872.54KC$ -1.20M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 749.25KC$ 1.62MC$ 1.15MC$ 990.08KC$ 1.10M
Total AssetsC$ 5.68MC$ 6.01MC$ 5.58MC$ 5.47MC$ 5.62M
Total DebtC$ 9.25MC$ 9.16MC$ 8.67MC$ 7.57MC$ 6.86M
Net DebtC$ 8.50MC$ 7.54MC$ 7.52MC$ 6.58MC$ 5.75M
Total LiabilitiesC$ 14.09MC$ 13.02MC$ 11.83MC$ 10.88MC$ 9.76M
Stockholders EquityC$ -10.56MC$ -9.19MC$ -8.49MC$ -7.76MC$ -6.52M
Cash Flow-
Free Cash FlowC$ -735.69KC$ -748.06KC$ 323.73KC$ -971.86K-
Operating Cash FlowC$ -789.89KC$ -715.27KC$ 382.38KC$ -959.36K-
Investing Cash FlowC$ -12.20KC$ -32.79KC$ -58.65KC$ -12.50K-
Financing Cash FlowC$ 597.84KC$ 1.23MC$ -167.67KC$ 857.04K-
Currency in CAD

Kane Biotech Earnings and Revenue History

Kane Biotech Debt to Assets

Kane Biotech Cash Flow

Kane Biotech Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis